Security key
426897104
Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (HEPA)
CUSIP: 426897104
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 75,674
- Total 13F value
- $58,764
- Share change
- +3
- SEC-reported price per share
- $1.00
- Number of holders
- 7
- Value change
- +$3
- Number of buys
- 3
- Shares outstanding
- 29,123,952
Holder snapshot
5 signals
Security identity
1 source field
Report period
Q1 2023
Institutions
7
Top holders
8
HEPA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2023
Previous quarter: Q4 2022
Hepion Pharmaceuticals, Inc. SEC filings
Hepion Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 426897104
Recent filing periods:
Ownership snapshot
Top reported holders of HEPA - Hepion Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
Lead comparable stake: 11%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
VANGUARD GROUP INC
11%
BlackRock Finance, Inc.
5.5%
GEODE CAPITAL MANAGEMENT, LLC
2.3%
STATE STREET CORP
1.1%
RENAISSANCE TECHNOLOGIES LLC
0.84%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
11%
|
$994,047
3,310,180 shares
|
— | 31 Dec 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
5.5%
|
$479,748
1,597,566 shares
|
— | 31 Dec 2022 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
2.3%
|
$197,000
656,453 shares
|
— | 31 Dec 2022 |
| STATE STREET CORP |
13F
Company
|
1.1%
|
$94,081
313,500 shares
|
— | 31 Dec 2022 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.84%
|
$74,000
245,600 shares
|
— | 31 Dec 2022 |
| ENVESTNET ASSET MANAGEMENT INC |
13F
Company
|
0.7%
|
$60,954
202,978 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
75,674
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
7
Q1 2023 holders
7
Holder diff
0
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend